CRT 2009 Preliminary Program March 4 - 6, 2009 click below to open: Preliminary Program (PDF)
click below to open:
Preliminary Program (PDF)
Poll Archives
8/21/2008 Drug-Eluting Stents Versus Bare Metal Stents for Narrowing in Saphenous Vein GraftsT Okabe, J Lindsay, AN Buch, et al.8/21/2008 Impact of Mild or Moderate Renal Insufficiency on the Intravascular Ultrasonic Analysis of Chronic Vascular Response to Paclitaxel-Eluting and Bare-Metal Stents (from the TAXUS IV, V, and VI Trials)J Aoki, GS Mintz, NJ Weissman, et al.8/21/2008 Effect of Prolonged Thienopyridine Use After Drug-Eluting Stent Implantation (from the TAXUS Landmark Trials Data)GW Stone, SG Ellis, A Colombo, et al.8/21/2008 Impact of Optimal Medical Therapy and Revascularization on Outcome of Patients With Chronic Kidney Disease and on Dialysis Who Presented With Acute Coronary SyndromeL Bonello, A De Labriolle, P Roy, et al.8/15/2008 Bivalirudin versus Unfractionated Heparin during Percutaneous Coronary InterventionA Kastrati, F-J Neumann, J Mehilli, et al.8/15/2008 Effect of PCI on Quality of Life in Patients with Stable Coronary DiseaseWS Weintraub, JA Spertus, P Kolm, et al.
About/Contact UsCRT 2009 Call for AbstractsCRT 2009 Meeting InformationSYNTAX (SYNergy between PCI with TAXUS and Cardiac Surgery)CASPAR (Coronary Artery Spasm In Patients With Acute Coronary Syndrome)
Preliminary Agendas: March 4, 2009: Neurovascular March 5, 2009: Peripheral Arterial Disease March 6, 2009: Aortic / Visceral / Venous click on a title above to view the preliminary agenda Antiplatelet Resistance: What Does it Mean and What Should/Can we Do About it? Dominick J. Angiolillo, MD, PhD Time to Treatment (and Transport) Issues: Selection of Reperfusion Modality, and Primary Angioplasty with No On-Site Surgery Eric R. Bates, MD Approaches to Shortening Door-to-Balloon Time: The Minneapolis Ambulance Triage Program Timothy D. Henry, MD
Preliminary Agendas: March 4, 2009: Neurovascular March 5, 2009: Peripheral Arterial Disease March 6, 2009: Aortic / Visceral / Venous click on a title above to view the preliminary agenda
8/27/2008 Colorado University and Boulder Biotech Company Team Up To Study Pythons For Clues To Heart Disease8/27/2008 Boston Scientific Announces Schedule for European Society of Cardiology Congress 20088/27/2008 Circulation: Cardiovascular Genetics Debuts in October8/19/2008 St. Jude Medical Announces CE Mark Approval and FDA Clearance for New Family of HIFU Surgical Ablation Products8/19/2008 Abbott and AstraZeneca Expand Relationship to Include Co-Promotion of CRESTOR®8/18/2008 Atritech Files for Pre-market Approval Application for its WATCHMAN® LAA Closure Technology8/12/2008 MIV Announces Excellent Safety and Efficacy of VESTAsynctm Polymer-Free Drug-Eluting Stent at 12-Month Clinical Follow Up